Back to 
Arrowstreet Capital, Limited Partnership
Arrowstreet Capital, Limited Partnership
VIVO
Showing 0 of 10 quarters
Position history for Arrowstreet Capital, Limited Partnership's holdings in MERIDIAN BIOSCIENCE INC
No. Arrowstreet Capital exited its VIVO (Meridian Bioscience) position in Q1 2021. Its Q4 2020 13F listed 469,032 shares worth $8.8M. Arrowstreet Capital already held VIVO in its Q4 2018 13F, the earliest on record, and held it in 9 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.